104Shibuya M: Pathology and molecular genetics of meningioma: recent advances. Neurol Med Chir (Tokyo) 2015;55:14–27.
105Thompson LD, Gyure KA: Extracranial sinonasal tract meningiomas: a clinicopathologic study of 30 cases with a review of the literature. Am J Surg Pathol 2000;24:640–650.
106Ho KL: Primary meningioma of the nasal cavity and paranasal sinuses. Cancer<italic></italic>1980;46:1442–1447.
107Broich G, Pagliari A, Ottaviani F: Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumour in 1924. Anticancer Res 1997;17:2683–2706.
108Jethanamest D, Morris LG, Sikora AG, Kutler DI: Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors. Arch Otolaryngol Head Neck Surg 2007;133:276–280.
109Platek ME, Merzianu M, Mashtare TL, et al: Improved survival following surgery and radiation therapy for olfactory neuroblastoma: analysis of the SEER database. Radiat Oncol 2011;6:41.
110Mills SE: Neuroectodermal neoplasms of the head and neck with emphasis on neuroendocrine carcinomas. Mod Pathol 2002;15:264–278.
111Thompson LD: Olfactory neuroblastoma. Head Neck Pathol 2009;3:252–259.
112Saade RE, Hanna EY, Bell D: Prognosis and biology in esthesioneuroblastoma: the emerging role of Hyams grading system. Curr Oncol Rep 2015;17:423.
113Tajudeen BA, Arshi A, Suh JD, St John M, Wang MB: Importance of tumor grade in esthesioneuroblastoma survival: a population-based analysis. JAMA Otolaryngol Head Neck Surg 2014;140:1124–1129.
114Malouf GG, Casiraghi O, Deutsch E, Guigay J, Temam S, Bourhis J: Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome. Eur J Cancer 2013;49:1324–1334.
115Hafezi S, Seethala RR, Stelow EB, et al: Ewing’s family of tumors of the sinonasal tract and maxillary bone. Head Neck Pathol 2011;5:8–16.
116Holsinger FC, Hafemeister AC, Hicks MJ, Sulek M, Huh WW, Friedman EM: Differential diagnosis of pediatric tumors of the nasal cavity and paranasal sinuses: a 45-year multi-institutional review. Ear Nose Throat J 2010;89:534–540.
117Whaley JT, Indelicato DJ, Morris CG, et al: Ewing tumors of the head and neck. Am J Clin Oncol 2010;33:321–326.
118Balatsouras DG, Eliopoulos PN, Economou CN: Multiple glomus tumours. J Laryngol Otol<italic></italic>1992;106:538–543.
119Woodruff JM, Huvos AG, Erlandson RA, Shah JP, Gerold FP: Neuroendocrine carcinomas of the larynx. A study of two types, one of which mimics thyroid medullary carcinoma. Am J Surg Pathol 1985;9:771–790.
120Lack EE, Cubilla AL, Woodruff JM: Paragangliomas of the head and neck region. A pathologic study of tumors from 71 patients. Hum Pathol 1979;10:191–218.
121Prasad ML, Jungbluth AA, Iversen K, Huvos AG, Busam KJ: Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa. Am J Surg Pathol 2001;25:782–787.
122Thompson LD, Wieneke JA, Miettinen M: Sinonasal tract and nasopharyngeal melanomas: a clinicopathologic study of 115 cases with a proposed staging system. Am J Surg Pathol 2003;27:594–611.
123Hodi FS, Corless CL, Giobbie-Hurder A, et al: Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin. J Clin Oncol 2013;31:3182–3190.
124Turri-Zanoni M, Medicina D, Lombardi D, et al: Sinonasal mucosal melanoma: molecular profile and therapeutic implications from a series of 32 cases. Head Neck 2013;35:1066–1077.
125Lazarev S, Gupta V, Hu K, Harrison LB, Bakst R: Mucosal melanoma of the head and neck: a systematic review of the literature. Int J Radiat Oncol Biol Phys<italic></italic>2014;90:1108–1118.
126Lund VJ, Chisholm EJ, Howard DJ, Wei WI: Sinonasal malignant melanoma: an analysis of 115 cases assessing outcomes of surgery, postoperative radiotherapy and endoscopic resection. Rhinology 2012;50:203–210.
127Dauer EH, Lewis JE, Rohlinger AL, Weaver AL, Olsen KD: Sinonasal melanoma: a clinicopathologic review of 61 cases. Otolaryngol Head Neck Surg 2008;138:347–352.
128Bachar G, Loh KS, O’Sullivan B, et al: Mucosal melanomas of the head and neck: experience of the Princess Margaret Hospital. Head Neck 2008;30:1325–1331.
129Rodriguez J, Romaguera JE, Manning J, et al: Nasal-type T/NK lymphomas: a clinicopathologic study of 13 cases. Leuk Lymphoma 2000;39:139–144.
130Jaffe ES, Chan JK, Su IJ, et al: Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 1996;20:103–111.
131Abbondanzo SL, Wenig BM: Non-Hodgkin’s lymphoma of the sinonasal tract. A clinicopathologic and immunophenotypic study of 120 cases. Cancer 1995;75:1281–1291.
132Kent SE, Majumdar B: Metastatic tumours in the maxillary sinus. A report of two cases and a review of the literature. J Laryngol Otol 1985;99:459–462.
133Flocks RH, Boatman DL: Incidence of head and neck metastases from genito-urinary neoplasms. Laryngoscope 1973;83:1527–1539.
Michelle Williams, MD
Department of Pathology, The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd, Unit 85
Houston, TX 77030 (USA)
E-Mail [email protected]
Nicolai P, Bradley PJ (eds): Anterior Skull Base Tumors. Adv Otorhinolaryngol. Basel, Karger, 2020, vol 84, pp 28–45 (DOI: 10.1159/000457923)
______________________
The Role of Morphologic and Functional Imaging in Pretreatment Assessment
Roberto Maroldi Andrea Borghesi Marco Ravanelli Salvatore Golemi Davide Farina
Department of Radiology, University of Brescia, Brescia, Italy
______________________